Press release -
Biopsy Devices Market Globally is projected to reach USD 3 Billion from 2018 to 2024
Access full Research:
Get Free Customization in this Report
Biopsy Devices Market Globally is projected to reach USD 3 Billion, experiencing a significant growth from 2018 to 2024. Biopsy Devices consist of tools or systems which are used for the diagnosis and treatment of cancer prevalence and increasing demand for minimally invasive procedures.
The cases of increasing cancer prevalence, such as breast, prostate, & lung, with the shift towards minimally invasive surgeries and increasing geriatric population, are driving the growth of this market. The rapid technological advancements and raising public awareness are also the driving factors for the Biopsy Devices market.
Renub Research report titled “Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)” provides a complete analysis of Global Biopsy Devices Market.
Request a free sample copy of the report:http://www.renub.com/contactus.php
By Segment – Biopsy Devices Market Analysis
Biopsy Needles is an attractive market in global Biopsy Devices market. While with the rising implementation of Biopsy Guns in surgery, this segment is expected to grow at a significant rate during the forecast period. Further, the report also covers the market of Guidance system (Ultrasound-guided, Stereotactic-guided, Clinically-guided and Reagents & kits system. The market for above mentioned equipments are positively influenced by factors like increasing cancer prevalence, such as breast, prostate, & lung, with the shift towards minimally invasive surgeries.
Breast Biopsy and Lung Biopsy market share holds significant percentage of Biopsy Devices Market. Prostate Biopsy market share is growing year on year.
Geographically, North America and Europe holds the considerable market share of the Biopsy Devices Market. Asia-Pacific Biopsy Devices Market is expected to grow at the faster rate over the forecasting period.
The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.
All the 8 companies studied in the report have been studied from 4 points
• Business Strategy – This section provides company marketing strategy
• Merger & Acquisition – This section captures 5 years M&A data
• Financial Insight – This section provides sales of (2010 to 2017) & forecast (2018 to 2024)
This 154 page report with 59 Figures and 2 Tables provides a complete analysis of the Global Biopsy Devices Market, Forecast key Growth Drivers and Challenges.
Biopsy Segments Covered in the Report:
• Guidance Systems
• Biopsy Guns
• Reagents and kits
Regional Market Covered in the Report:
• Rest of the World
Key Companies Covered in the Report:
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Olympus Corporation
• Boston Scientific Corporation
• Medtronic plc
• Hologic, Inc.
Sr. Marketing Manager
- biopsy devices market application
- biopsy devices market regions
- biopsy devices market by products
- global biopsy devices market
- biopsy devices market
- biopsy devices
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.